The Ins and Outs of RAS Effector Complexes

Area of Science:

• Oncology
• Molecular Biology
• Bioinformatics

Background:

• RAS oncogenes are frequently mutated in human cancers, regulating critical cellular processes like proliferation and survival.
• RAS-dependent signaling pathways are dysregulated in over 50% of human cancers, presenting a significant therapeutic challenge.
• Targeting mutant RAS proteins and their downstream pathways has historically been difficult due to pathway complexity.

Purpose of the Study:

• To review recent advances in understanding RAS signaling.
• To integrate detailed mechanistic studies with global functional and computational studies.
• To identify new therapeutic strategies for RAS-mutated cancers.

Main Methods:

• Review of detailed molecular studies.
• Analysis of large-scale omics data.
• Application of computational modeling and data integration.

Main Results:

• A comprehensive understanding of RAS signaling intricacies, including regulation of physiological and pathophysiological functions.
• Establishment of connections between detailed mechanistic insights and global functional studies.
• Identification of opportunities for mechanism-based therapeutic interventions.

Conclusions:

• Recent integrated research provides a deeper understanding of RAS signaling.
• Computational modeling and data integration are crucial for actionable insights.
• This knowledge facilitates the design of novel therapies for RAS-mutated cancers.